Why the study?
Does anticoagulation combined with antiplatelet therapy reduce embolic events without increasing bleeding in patients with first AMI complicated by LV thrombus?
Does anticoagulation combined with antiplatelet therapy reduce embolic events without increasing bleeding in patients with first AMI complicated by LV thrombus?
In patients with a first AMI complicated by LV thrombus, combining anticoagulation with antiplatelet therapy may reduce embolic events without increasing bleeding risk.
May support anticoagulation plus antiplatelet therapy after AMI with LV thrombus; leaves open need for randomized confirmation.
Appropriate anticoagulation therapy may decrease the incidence of embolic events without increasing the incidence of bleeding events in patients with first AMI complicated by LV thrombus.
No takes yet. Share an insight, caveat, or question.
Maniwa et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: